Evolent Health, Inc.
EVH
$9.19
-$0.80-8.01%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.20B | 2.40B | 2.55B | 2.46B | 2.35B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.20B | 2.40B | 2.55B | 2.46B | 2.35B |
| Cost of Revenue | 1.84B | 2.03B | 2.19B | 2.07B | 1.92B |
| Gross Profit | 359.26M | 365.72M | 367.35M | 393.27M | 437.01M |
| SG&A Expenses | 265.19M | 258.32M | 250.39M | 248.18M | 267.89M |
| Depreciation & Amortization | 106.20M | 112.93M | 118.37M | 118.68M | 121.38M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.21B | 2.40B | 2.56B | 2.44B | 2.31B |
| Operating Income | -12.12M | -5.53M | -1.40M | 26.41M | 47.74M |
| Income Before Tax | -131.55M | -109.47M | -63.04M | -87.18M | -94.30M |
| Income Tax Expenses | -1.10M | -508.00K | -1.41M | -14.95M | -19.88M |
| Earnings from Continuing Operations | -130.45 | -108.96 | -61.62 | -72.23 | -74.42 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -130.45M | -108.96M | -61.62M | -72.23M | -74.42M |
| EBIT | -12.12M | -5.53M | -1.40M | 26.41M | 47.74M |
| EBITDA | 113.29M | 125.52M | 135.09M | 119.19M | 142.92M |
| EPS Basic | -1.61 | -1.22 | -0.81 | -0.91 | -0.94 |
| Normalized Basic EPS | -0.53 | -0.47 | -0.13 | 0.02 | 0.11 |
| EPS Diluted | -1.61 | -1.22 | -0.81 | -0.91 | -0.94 |
| Normalized Diluted EPS | -0.53 | -0.47 | -0.13 | 0.02 | 0.11 |
| Average Basic Shares Outstanding | 461.09M | 459.90M | 458.72M | 457.28M | 454.70M |
| Average Diluted Shares Outstanding | 461.09M | 459.90M | 458.72M | 457.28M | 454.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -14.67% | -17.97% | -32.59% | -28.30% | -27.42% |